Endogenous opioid tone in patients with rheumatoid arthritis

British Journal of Rheumatology

Volumn 35, Issue 5, 1996, Pages 436-440

  Kassimos, D ^a   Choy, E H S ^a   Grossman, A B ^b   Chikanza, I C ^c   Panayi, G S ^a,d  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^c ROYAL LONDON HOSPITAL   (United Kingdom)

^d GUY S HOSPITAL   (United Kingdom)

Author keywords

ACTH; Cortisol; Endogenous opioid; Hypothalamus pituitary adrenal axis; Naloxone; Opiate; Prolactin; Rheumatoid arthritis

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; ENDORPHIN; HYDROCORTISONE; NALOXONE; OPIATE ANTAGONIST; PROLACTIN;

ADULT; AGED; ARTICLE; CHRONIC PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HORMONE SYNTHESIS; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM; TIME;

EID: 0030004284     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/35.5.436     Document Type: Article

References (19)

1. Chikanza IC, Petrou P, Kingsley GH, Chrousos G, Panayi G. Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthritis Rheum 1992;35:1281-8.
2. Grossman A, Gaillard RC, McCarthney P, Rees LH, Besser GM. Opiate modulation of the pituitary-adrenal axis: effect of stress and circadian rhythm. Clin Endocrinol 1982;17:279-86.
3. Grossman A, Moult PJA, Cunnah D, Besser M. Different opioid mechanisms are involved in the modulation of ACTH and gonadotrophin release in man. Neuroendocrinology 1986;42:357-60.
4. Martin del Campo AF, McMurray RG, Besser GM, Grossman A. Effect of the 12 hour infusion of Naloxone on mood and cognition in normal male volunteers. Biol Psychiatry 1992;32:344-53.
5. McMurray RG, Newbould E, Bouloux P, Besser GM, Grossman A. High dose naloxone modifies cardiovascular and neuroendocrine function in ambulant subjects. Psychoneuroendocrinology 1991;16:447-55.
6. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
7. Cunnah D, Jessop DS, Besser GM, Rees LH. Measurement of circulating corticotrophin-releasing factor in man. J Endocrinol 1987;113:123-31.
8. Ngai SH, Berkowitz B, Yang JC, Hempstread J, Spector S. Pharmacokinetics of naloxone in rats and in man. Anesthesiology 1976;44:398-401.
9. Bouloux PMG, Newbould E, Causon R et al. Different effect of high dose naloxone on the plasma adrenaline response to the coldpressor test. Clin Sci 1989;76: 625-30.
10. Delitala G, Trainer PJ, Oliva O, Fanciulli G, Grossman AB. Opioid peptide and adrenoceptor pathways in the regulation of the pituitary-adrenal axis in man. J Endocrinol 1994;141:163-8.
11. Cohen MR, Cohen RM, Pickar D, Weingart H, Murphy DL. High dose naloxone infusion in normals. Dose dependent behaviour, hormonal, and physiological responses. Arch Gen Psychiatry 1983;40:613-9.
12. Cohen NM, Cohen RM, Pickar D, Weingartner H, Murphy DL, Bunney VYT. Behavioural effect after high dose naloxone administration to normal volunteers. Lancet 1981;2:1110.
13. Blankstein J, Reyes F, Winter J, Faiman C. Effects of naloxone on prolactin and cortisol in normal women. Proc Soc Exp Biol Med 1980;164:363-5.
14. Grossman A, Stubbs WA, Gaillard RC, Delitalia G, Rees LH, Bresser GM. Studies of the opiate control of prolactin, GH and TSH. Clin Endocrinol 1981;14: 381-6.
15. Sawynock J, Pinsky C, Labella FS. New review on the specificity of naloxone as an opiate antagonist. Life Sci 1979;25:1621-3.
16. Volanka V, Cho D, Mallya A, Bauman J. Naloxone increases ACTH and cortisol levels in man. N Engl J Med 1979;300:1056-7.
17. Patcher VK, Mastorakos G, Brady LS, Redwine A, Wilder RL, Chrousos G. Increased arginine vasopressin secretion may participate in the enhanced susceptibility of Lewis rats to inflammatory disease. Neuroendocrinology 1993;58:106-10.
18. Hockings GI, Grice JE, Walters MM, Crosbie GV, Torpy DJ, Jackson RV. A synergistic adrenocorticotrophin release to naloxone and vasopressin in normal humans: evidence that naloxone stimulates endogenous corticotrophin-releasing hormone. Clin Endocrinol 1995;61:198-206.
19. Chikanza IC, Petrou P, Chrousos G, Kingsley G, Panayi GS. Excessive and dysregulated secretion of prolactin in rheumatoid arthritis: Immunopathogenetic and therapeutic implications. Br J Rheumatol 1993;32:445-8.